Jørgen Ankill

6PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersStatistical and quantitative geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 18, 2024
Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation.

Jørgen Ankill, Zhi Zhao, Xavier Tekpli

|Apr 27, 2024
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

Thomas Fleischer, Mads Haugland Haugen, Jørgen Ankill

|Mar 15, 2024
Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.

Anastasia Brativnyk, Jørgen Ankill, Åslaug Helland

|Dec 23, 2022
Transcriptomic pan-cancer analysis using rank-based Bayesian inference.

Valeria Vitelli, Thomas Fleischer, Jørgen Ankill

|Mar 30, 2022
Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancer.

Jørgen Ankill, Miriam Ragle Aure, Sunniva Bjørklund

|Apr 30, 2021
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.

Miriam Ragle Aure, Thomas Fleischer, Sunniva Bjørklund

Pageof 1

Frequent Collaborators

6 joint publications

Thomas Fleischer

2 joint publications

Miriam Ragle Aure

2 joint publications

Anthony Mathelier

2 joint publications

Xavier Tekpli